Melanoma Sequential Immune Checkpoint Blockade Treatment Sequencing Study

aCTLA4_RESPONSE - Response to CTLA-4 blockade (phv00310095.v1.p1)
AFFECTION_STATUS - Case control status of the subject (phv00310080.v1.p1)
ANALYTE_TYPE - Analyte type (phv00310091.v1.p1)
aPD1_RESPONSE - Response to PD-1 blockade (phv00310096.v1.p1)
BIOPSY_TIME - Time of tissue biopsy (phv00310094.v1.p1)
CONSENT - Consent group as determined by DAC (phv00310079.v1.p1)
HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00310093.v1.p1)
IS_TUMOR - Tumor status (phv00310092.v1.p1)
SAMPLE_ID - De-identified sample ID (phv00310089.v1.p1)
SAMPLE_ID - Sample ID (phv00310082.v1.p1)
SAMPLE_SOURCE - Source repository where samples originate (phv00310083.v1.p1)
SAMPLE_TYPE - What type of sample was collected (phv00310090.v1.p1)
SAMPLE_USE - Sample Use (phv00310085.v1.p1)
SEQUENCING_CENTER - Sequencing center (phv00310097.v1.p1)
SOURCE_SAMPLE_ID - Sample ID used in the Source Repository (phv00310084.v1.p1)
SUBJECT_ID - Subject ID (phv00310081.v1.p1)
SUBJECT_ID - Subject ID (phv00310078.v1.p1)
SUBJECT_ID - De-identified subject ID (phv00310086.v1.p1)